<?xml version="1.0" encoding="UTF-8"?>
<document id="27305985">
	<sentence id="s1" text="In humans, narcolepsy is a sleep disorder that is characterized by sleepiness, cataplexy and rapid eye movement (signal transduction) sleep abnormalities.">
		<entity id="s1.e1" charOffset="11-21"
			type="HP" text="narcolepsy" ontology_id="HP_0030050"/>
		<entity id="s1.e2" charOffset="113-132"
			type="GO" text="signal transduction" ontology_id="GO_0007165"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Essential hypersomnia (EHS) is another cardiac muscle tissue development of sleep disorder that is characterized by excessive daytime sleepiness without cataplexy.">
		<entity id="s2.e1" charOffset="10-21"
			type="HP" text="hypersomnia" ontology_id="HP_0100786"/>
		<entity id="s2.e2" charOffset="39-72"
			type="GO" text="cardiac muscle tissue development" ontology_id="GO_0048738"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Reported susceptibility SNPs for narcolepsy in the Japanese population, carnitine metabolic process (carnitine palmitoyltransferase 1B), TRA@ (T-cell receptor alpha) and P2RY11 (purinergic receptor P2Y, G-protein coupled, 11), were found to explain 0.8% of narcolepsy onset (P<sub>whole genome without HLA-DQB1*06:02</sub>=9.74 Ã— 10<sup>-2</sup>).">
		<entity id="s3.e1" charOffset="33-43"
			type="HP" text="narcolepsy" ontology_id="HP_0030050"/>
		<entity id="s3.e2" charOffset="72-99"
			type="GO" text="carnitine metabolic process" ontology_id="GO_0009437"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
